<abstract xmlns="http://www.w3.org/1999/xhtml">

<p>The emergence of the novel SARS-CoV-2 coronavirus and rapid spread of the COVID-19 disease it causes in late 2019 and early 2020 has since led to a global pandemic announced by the World Health Organization (WHO). The pandemic is a steadily growing social, economic, psychological, and health burden. The infection rates worldwide are climbing. COVID-19 is considered a systemic disease, potentially resulting in acute respiratory distress and cardiovascular failure leading to death. Yet, SARS-CoV-2, a novel and still under-studied virus, has been documented to cause a large variety of symptoms, in many cases including cutaneous manifestations.</p>
<p>This paper is a review of medical literature available to date regarding the cutaneous manifestations in the course of SARS-CoV-2 infection. It is also aimed at discussing the significance of dermatological findings for improved diagnosis and treatment of COVID-19 patients. Considering the gravity of the novel coronavirus pandemic, an improved dermatological approach would aid timely diagnosis and effective management of COVID-19, and would facilitate classification of the cutaneous abnormalities observed.</p>
</abstract>

The emergence of the novel SARS-CoV-2 coronavirus and rapid spread of the COVID-19 disease it causes in late 2019 and early 2020 has since led to a global pandemic announced by the World Health Organization (WHO). The pandemic is a steadily growing social, economic, psychological, and health burden. The infection rates worldwide are climbing. COVID-19 is considered a systemic disease, potentially resulting in acute respiratory distress and cardiovascular failure leading to death. Yet, SARS-CoV-2, a novel and still under-studied virus, has been documented to cause a large variety of symptoms, in many cases including cutaneous manifestations.
This paper is a review of medical literature available to date regarding the cutaneous manifestations in the course of SARS-CoV-2 infection. It is also aimed at discussing the significance of dermatological findings for improved diagnosis and treatment of COVID-19 patients. Considering the gravity of the novel coronavirus pandemic, an improved dermatological approach would aid timely diagnosis and effective management of COVID-19, and would facilitate classification of the cutaneous abnormalities observed.

Cutaneous manifestations and SARS-CoV-2 infection

Department of Cosmetology, Chair of Cosmetology School of Pharmaceutical Science

Postępy Higieny i Medycyny Doświadczalnej

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

{"article-title":"Cutaneous manifestations and SARS-CoV-2 infection"}

The emergence of the novel SARS-CoV-2 coronavirus and rapid spread of the COVID-19 disease it causes in late 2019 and early 2020 has since led to a global...

Cutaneous manifestations and SARS-CoV-2 infection

Article Category: Review

Publié en ligne: 14 mars 2022

Pages: 1038 - 1045

Reçu: 20 janv. 2021

Accepté: 17 mai 2021

DOI: https://doi.org/10.2478/ahem-2021-0040

Mots clés
Cutaneous manifestations, SARS-CoV-2 infection, vesicular and vascular skin lesions, dyshidrotic eczema, urticarial rash

© 2021 Dawid Burczyk et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Cutaneous manifestations and SARS-CoV-2 infection

Article Category: Review

Publié en ligne: 14 mars 2022

Pages: 1038 - 1045

Reçu: 20 janv. 2021

Accepté: 17 mai 2021

DOI: https://doi.org/10.2478/ahem-2021-0040

Mots clésCutaneous manifestations, SARS-CoV-2 infection, vesicular and vascular skin lesions, dyshidrotic eczema, urticarial rash

© 2021 Dawid Burczyk et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mots clés
Cutaneous manifestations, SARS-CoV-2 infection, vesicular and vascular skin lesions, dyshidrotic eczema, urticarial rash